Metropolis Healthcare Limited provides pathology and diagnostic laboratory services in India and internationally. The company offers clinical laboratory testing, and profiles and support services to patients, smaller labs, nursing homes, and hospitals. It provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. The company's tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. It also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2020, the company operated 124 clinical laboratories, 9,000 pick-up points, and 598 assisted referral centers. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India. The ISIN of this stock is INE112L01020.